We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




New Technique Reduces Recalls for Breast Tomosynthesis Patients

By MedImaging International staff writers
Posted on 21 Feb 2017
Print article
Image: A graph showing the percentage of breast exams every year during the study period (Photo courtesy of RSNA).
Image: A graph showing the percentage of breast exams every year during the study period (Photo courtesy of RSNA).
The results of a new study show that a novel breast tomosynthesis technique using synthesized 2D compiled images of the breast may enable improved invasive cancer detection, and reduced radiation exposure.

The researchers have shown that the new technique, called DBT-s2D, resulted in a 4.3% recall rate, compared to a 5.8% recall rate for patients undergoing screening using standard digital breast tomosynthesis and mammography.

The study was carried out by researchers at the Christiana Care Health System’s Helen F. Graham Cancer Center & Research Institute, and was published online in the February 2017 issue of the journal Radiology.

The results of the study suggest that a combination of s2D mammography and Digital Breast Tomosynthesis (DBT) could reduce the screening recall rate for additional examinations while providing the same levels of cancer detection. The new technique could also reduce the number of false-positive findings, and may make Full-Field Digital Mammography (FFDM) unnecessary.

Jacqueline S. Holt, MD, FACR, director Breast Imaging, Christiana Care Health System’s Helen F. Graham Cancer Center & Research Institute, said, "The adoption of s2D mammography combined with DBT into screening programs would limit radiation exposure to the patient, and, on the basis of our results, may improve clinical performance. If synthesized 2-D imaging is performed, you’ll get equal or better patient outcomes and go to a lower radiation dose. These findings could be a practice-changer globally. The downstream cost reduction when women don’t need to be called back for additional imaging amounts to millions of healthcare dollars saved. A lot of the controversy surrounding screening mammography is about false-positive findings. With this method, we are addressing this issue, optimizing patient care and adding value."

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Under Table Shield
3 Section Double Pivot Under Table Shield
New
Self-Driving Mobile C-arm
CIARTIC Move
New
DR Flat Panel Detector
1500L

Print article

Channels

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.